Persistent use of a low molecular weight heparin, certoparin, at therapeutic dosage does not result in thrombocytopenia despite the generation of anti-heparin-PF4 antibodies - Walenga,J.M.; Ahmad,S.; Hoppensteadt,D.A. (Blood, 1999)